Diebold Nixdorf (DBD) Tops Q2 EPS by 52c, Trims Guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $72.24 --0%
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q2 EPS of $0.38, $0.52 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $851.7 million versus the consensus estimate of $906.7 million.
GUIDANCE:
Diebold Nixdorf sees FY2022 revenue of $3.55-3.75 billion, versus the consensus of $3.74 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
